Evidence map›Paper›PMID 20823320›Full record

ArticleBioinformatics (Oxford, England)2010

Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism.

Luis Tari, Saadat Anwar, Shanshan Liang, James Cai, Chitta Baral

Abstract readEvaluation Study
In one paragraph

Article in Bioinformatics (Oxford, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. A computational approach to predict multi-pathway drug-drug interactions: A case study of irinotecan, a colon cancer medication.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Article
  12. Review
  13. Article
  14. Article
  15. An Informatics-based Approach to Identify Key Pharmacological Components in Drug-Drug Interactions.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2020
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Deep learning improves prediction of drug-drug and drug-food interactions.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luis TariDisease and Translational Informatics, Hoffmann-La Roche, Nutley, NJ 07110, USA. luis.tari@roche.com
Saadat Anwar
Shanshan Liang
James Cai
Chitta Baral

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationIdentifying drug-drug interactions (DDIs) is a critical process in drug administration and drug development. Clinical support tools often provide comprehensive lists of DDIs, but they usually lack the supporting scientific evidences and different tools can return inconsistent results. In this article, we propose a novel approach that integrates text mining and automated reasoning to derive DDIs. Through the extraction of various facts of drug metabolism, not only the DDIs that are explicitly mentioned in text can be extracted but also the potential interactions that can be inferred by reasoning.

resultsOur approach was able to find several potential DDIs that are not present in DrugBank. We manually evaluated these interactions based on their supporting evidences, and our analysis revealed that 81.3% of these interactions are determined to be correct. This suggests that our approach can uncover potential DDIs with scientific evidences explaining the mechanism of the interactions.

Indexed as

Data MiningDrug InteractionsDatabases, FactualEnzymesFeasibility StudiesHumansLogicNatural Language ProcessingPharmaceutical PreparationsEnzymesPharmaceutical Preparations

Identifiers

PMID20823320
PMCPMC2935409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.